Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Factual Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Arrhythmia Research Technology Inc Announces Delay In Finalizing Q4, FY 2012 End Results


Wednesday, 17 Apr 2013 08:15am EDT 

Arrhythmia Research Technology Inc announced that it was unable to file its annual report on Form 10-K for the fiscal year ended December 31, 2012 within the automatic extension of its due date to April 16, 2013 afforded by its filing of a Form 12b-25 Notification of Late Filing with the Securities and Exchange Commission. The delay in filing is due to an ongoing internal review by the Audit Committee and the Company's independent auditor relating to the recognition of revenue with multiple element arrangements associated with respect to the tooling revenue. As of April 17, 2013, the audit is not complete. Consequently, the Company is unable to determine with reasonable certainty at this time the significance of any such adjustments and their effect on the net loss and total assets, total liabilities and stockholders' equity. Management is working diligently with its Audit Committee and the Company's independent auditor to determine whether any potential adjustments are required and the extent thereof. The Company expects to finalize the 10-K by April 26, 2013. However, until the review is complete and a final determination is made, the Company cannot provide further assurance regarding the results of operations for the affected periods or whether adjustments will be required. 

Company Quote

6.89
-0.11 -1.57%
11:02am EDT